SEC Form D private-offering filing

Sentrimed, Inc.

Name: Sentrimed, Inc. - new SEC Form D private-offering filing, Mullica Hill, NJ
Published: 2026-05-13

A new SEC Form D private-offering notice from Mullica Hill, NJ, a $1,000,000 filer-stated offering target in Biotech. The source filing is one click away.

Sentrimed, Inc. site↗ Verified via SEC Form D

Clinical stage biotech developing MASL, an oral therapeutic targeting podoplanin to block cancer cell proliferation, starting with head and neck cancer.

Filed 2026-05-13Filed to raise $1,000,000First money in 2026-05-08Raised so far $250,000HQ (as filed) Mullica Hill, NJSector Biotech ✓Stage (inferred) SeedCall status Call-ready

Source linked the Form D on EDGAR↗Website verified sentrimed.com↗Named in the filing 8 executives & directors

Open this row on the live feed →More new filings in New Jersey →More Biotech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.